ERBB2 and breast cancer: Kawiak et al. [12] proved that PLB inhibited the invasion of HER2-overexpressing breast cancer cells BT474 and SKBR3 by inhibiting IKKα-mediated NF-κB activation and downregulating NF-κB-regulated MMP-9 expression.